[Periprocedural high-dose statin strategy shown no benefits on clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary interventions].
Autor: | Li Y, Zhao SP, Li Y |
---|---|
Jazyk: | čínština |
Zdroj: | Zhonghua xin xue guan bing za zhi [Zhonghua Xin Xue Guan Bing Za Zhi] 2018 May 24; Vol. 46 (5), pp. 338-340. |
DOI: | 10.3760/cma.j.issn.0253-3758.2018.05.003 |
Databáze: | MEDLINE |
Externí odkaz: |